Tag:
FDA authorization
Internal Medicine
Personalized Medicine in Action: Stanford’s New Drug for Rare Blood Cancer
Fewer than half of people with a subtype of Myeloid/Lymphoid Neoplasms (MLN) are alive one year after diagnosis. This statistic underscores the critical need...
Internal Medicine
“Lenacapavir” – A Breakthrough in HIV Prevention, But Not Accessible to All
The United States Food and Drug Administration (FDA) has granted approval for Lenacapavir, an innovative, long-acting injectable drug, for HIV prevention. This decision represents...